310 related articles for article (PubMed ID: 35466867)
21. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
22. Concepts on Smart Nano-Based Drug Delivery System.
Rai S; Singh N; Bhattacharya S
Recent Pat Nanotechnol; 2022; 16(1):67-89. PubMed ID: 33494685
[TBL] [Abstract][Full Text] [Related]
23. Advances in Nanoparticles as Anticancer Drug Delivery Vector: Need of this Century.
Ali I; Mukhtar SD; Ali HS; Scotti MT; Scotti L
Curr Pharm Des; 2020; 26(15):1637-1649. PubMed ID: 32013826
[TBL] [Abstract][Full Text] [Related]
24. Targeted drug delivery systems for matrix metalloproteinase-responsive anoparticles in tumor cells: A review.
Guo F; Du Y; Wang Y; Wang M; Wang L; Yu N; Luo S; Wu F; Yang G
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128658. PubMed ID: 38065446
[TBL] [Abstract][Full Text] [Related]
25. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.
Khan MI; Hossain MI; Hossain MK; Rubel MHK; Hossain KM; Mahfuz AMUB; Anik MI
ACS Appl Bio Mater; 2022 Mar; 5(3):971-1012. PubMed ID: 35226465
[TBL] [Abstract][Full Text] [Related]
26. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
27. Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review.
Kenchegowda M; Rahamathulla M; Hani U; Begum MY; Guruswamy S; Osmani RAM; Gowrav MP; Alshehri S; Ghoneim MM; Alshlowi A; Gowda DV
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011376
[TBL] [Abstract][Full Text] [Related]
28. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
[TBL] [Abstract][Full Text] [Related]
29. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
[TBL] [Abstract][Full Text] [Related]
30. Passive and active tumour targeting with nanocarriers.
Hirsjärvi S; Passirani C; Benoit JP
Curr Drug Discov Technol; 2011 Sep; 8(3):188-96. PubMed ID: 21513482
[TBL] [Abstract][Full Text] [Related]
31. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
32. 'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective.
Fu L; Zhang Y; Farokhzad RA; Mendes BB; Conde J; Shi J
Chem Soc Rev; 2023 Oct; 52(21):7579-7601. PubMed ID: 37817741
[TBL] [Abstract][Full Text] [Related]
33. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
34. The ligand nanoparticle conjugation approach for targeted cancer therapy.
Karra N; Benita S
Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
[TBL] [Abstract][Full Text] [Related]
35. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
36. Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform.
Hopkins C; Javius-Jones K; Wang Y; Hong H; Hu Q; Hong S
Expert Opin Drug Deliv; 2022 Oct; 19(10):1337-1349. PubMed ID: 35949105
[TBL] [Abstract][Full Text] [Related]
37. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
[TBL] [Abstract][Full Text] [Related]
38. Nanotechnology in cancer therapy.
Aslan B; Ozpolat B; Sood AK; Lopez-Berestein G
J Drug Target; 2013 Dec; 21(10):904-13. PubMed ID: 24079419
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticles incorporated in nanofibers using electrospinning: A novel nano-in-nano delivery system.
Shetty K; Bhandari A; Yadav KS
J Control Release; 2022 Oct; 350():421-434. PubMed ID: 36002053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
